Evidence map›Paper›PMID 37022791›Full record

ReviewAntioxidants & redox signaling2023

Glioblastomas: Hijacking Metabolism to Build a Flexible Shield for Therapy Resistance.

Justine Bailleul, Erina Vlashi

Abstract readReview
In one paragraph

Review in Antioxidants & redox signaling, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. A bibliometric analysis of global research trends in autophagy and glioblastomas.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Justine BailleulDepartment of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
Erina VlashiDepartment of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.ORCID 0000-0002-2505-3577

Funding

Drivers of Metabolic Plasticity Promote Radiation Resistance in Glioblastoma MultiformeR01CA251872 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VLASHI, ERINA · 2020 to 2024
$2.8M
NCI NIH HHS R01 CA251872
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsBrain NeoplasmsGlioblastomaBrainCombined Modality TherapyHumansAntineoplastic Agentsglioblastomametabolismplasticityredox

Identifiers

PMID37022791
PMCPMC10655009

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.